日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Lantern Pharma completes LP-300 Lung cancer trial signup
Lantern Pharma Inc., an artificial intelligence (AI) company developing targeted cancer therapies…
Ebara Health Insurance rolls out Luna Luna Office Femtech
Ebara Health Insurance Association and LIFEM Co., Ltd. have agreed to introduce…
Protagenic Gets Japan Patent for Stilbenoid Drug Program
Protagenic Therapeutics, Inc. announces that on July 18, 2025, the Japanese Patent…
Asahi Kasei Opens New Plant to Boost Planova Output
Asahi Kasei Life Science will build a new spinning plant in Nobeoka…
Top 7 Digital Health Startups Revolutionizing Patient Monitoring in Japan
Japan is transforming the future of healthcare through digital health startups that…
Infocom Launches DigiPro AI Compliance Tool for Pharma
Infocom Corporation has launched the DigiPro® AI Compliance Check Service , which…
Pahr Therapeutics secures $14M to develop PAH therapies
Pahr Therapeutics has raised $14 million in seed funding. This money will…
Endoscopy AI System by AI Medical Gets Thai FDA Nod
AI MEDICAL SERVICE INC., a medical startup focused on the development of…
Latest Article
English